Jain PharmaBiotech, May 2012, Pages: 488
vaccines for avian influenza
Epitope-based vaccines for influenza
Gene-based vaccines for influenza
Live attenuated vaccines
MAbs for passive immunization against avian influenza
M2e-based human
Datamonitor, Nov 2011, Pages: 81
the major drivers and resistors of the current Chinese vaccine market. Understand the key opportunities and threats facing developers.
- Develop commercial strategies for operating in the Chinese vaccines
Business Insights, July 2010, Pages: 261
Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates Therapeutic vaccines promise a new wave of highly potent and highly specific
Espicom Business Intelligence Ltd, Jan 2010, Pages: 164
and will be vigilant for the opportunities offered by up-coming companies with promising new platform technologies.
Prophylactic vaccines: A high growth market
Our forecasts indicate that the prophylactic infectious
Business Insights, Jan 2005
reasons to order your copy today…
- Compare and contrast your company's vaccines pipeline against your top competitors, assess the strength of your pipeline and identify the potential opportunities you can
Datamonitor, May 2009, Pages: 131
of opportunities and challenges for the sector and a future outlook.
- In-depth analysis of key vaccine antigen delivery technologies
- Thorough assessment of the potential for selected vaccine antigen delivery
Decision Resources, Inc., Oct 2009, Pages: 36
and Human Services Grants to Companies for the Development of Cell-Based Influenza Vaccines
Figures
1. Seasonal vs. Pandemic Influenza
2. Creation of Influenza Vaccine Viral Strains Using Reassortment
3
Frost & Sullivan, Dec 2006, Pages: 125
of Disorders
---7. Coronary Artery Disease
---8. Peripheral Artery Disease
---9. Cancer
---10. DNA Vaccines
--3. Assessment of Stakeholder Innovation and Technology Transfer Opportunities--Influential
Decision Resources, Inc., May 2005, Pages: 13
of cancer vaccines will be able to use this acceptance to establish these treatments as viable therapeutic options. The first major launch of a cancer vaccine, designed to prevent human papillomavirus
Frost & Sullivan, Feb 1999
market. Profiles of key industry participants are included.
- Executive Summary
- Introduction to the Adult Infectious Disease Vaccine Market
- Summary of Major Findings
- Industry Opportunities
China Research & Intelligence, March 2012, Pages: 60
Vaccines
4.1.3 Import of Human Blood Products and Medical Animal Blood Products
4.2 Export of Chinese Bio-pharmaceutical Industry
4.2.1 Overview
4.2.2 Export of HumanVaccines
4.2.3 Export of Human Blood
TriMark Publications, Feb 2008, Pages: 286
.10 The Market Opportunity for the Use of Stem Cells in the Cancer Therapy Marketplace
4. Tumor Antigens, Cancer Vaccines and Cellular Therapy
4.1 Scope of this Chapter
4.2 Tumor Antigens and Classes
4.3 Classes
John Wiley and Sons Ltd, Nov 2008, Pages: 312
subunit vaccines targeting a tranche of current, major diseases. Yet such opportunities risk being squandered. Informatics techniques - which address issues of both data management and prediction, thereby
CCM International Limited, April 2010, Pages: 178
.5 Interferon
III-1.6 Anti-tumor monoclonal antibody
III-2 Blood products
III-3 Humanvaccines
III-4 Diagnostic reagent
III-4.1 Diagnostic reagent history in China
III-4.2 Current production situation
Decision Resources, Inc., Feb 2006, Pages: 17
Is There Commercial Opportunity in the Development of a New Influenza Vaccine? Influenza is a significant health issue. Influenza epidemics occur yearly, and recently, health groups such as the World
Decision Resources, Inc., Feb 2011, Pages: 24
Opportunities in Noninvasive Prenatal Diagnostics and Newborn Screening The push to improve detection of fetal abnormalities as early as possible with the use of non-invasive tests has prompted
Sheila Greco Associates, May 2011, Pages: 1
has one product on the market today: Nabi-HB [Hepatitis B Immune Globulin (Human)]. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial
Datamonitor, Feb 2011, Pages: 123
concerns, unmet needs and future opportunities lie by learning about the views of Chinese key hepatitis B opinion leaders.
- Review the clinical and commercial factors driving new product decisions
